Taro Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Taro Pharmaceutical Industries has a total shareholder equity of $1.8B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.2B and $384.1M respectively. Taro Pharmaceutical Industries's EBIT is $35.2M making its interest coverage ratio -0.7. It has cash and short-term investments of $902.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -0.7x |
Cash | US$902.22m |
Equity | US$1.78b |
Total liabilities | US$384.09m |
Total assets | US$2.16b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TAL's short term assets ($1.3B) exceed its short term liabilities ($374.1M).
Long Term Liabilities: TAL's short term assets ($1.3B) exceed its long term liabilities ($10.0M).
Debt to Equity History and Analysis
Debt Level: TAL is debt free.
Reducing Debt: TAL had no debt 5 years ago.
Debt Coverage: TAL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TAL has no debt, therefore coverage of interest payments is not a concern.